Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study

Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study

Abstract Kawasaki disease (KD) is an acute vasculitis predominantly affecting younger children, and intravenous immunoglobulin (IVIG) treatment can reduce coronary artery lesion (CAL) development. This multicenter retrospective study aimed to evaluate whether using 10% immunoglobulin products, which...

Full description

Saved in:
Bibliographic Details
Main Authors: Daichi Sajiki, Nobuhiro Nishio, Taichi Kato, Takashi Hirao, Kentaro Suzuki, Kiyotaka Go, Fumie Kinoshita, Hiroyuki Kidokoro, Jun-ichi Kawada, Yoshiaki Sato, Yoshiyuki Takahashi
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Children
Coronary artery lesion
Immunoglobulin products concentration
Immunoglobulin-related adverse event
Intravenous Immunoglobulin
Kawasaki disease
Online Access:https://doi.org/10.1038/s41598-025-03395-9
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items